Idiopathic pulmonary fibrosis: state of the art for 2023
AJ Podolanczuk, CC Thomson… - European …, 2023 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease characterised by
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …
worsening respiratory symptoms and physiological impairment. Increasing awareness of the …
Pulmonary hypertension associated with lung diseases
OA Shlobin, Y Adir, JA Barbera… - European …, 2024 - publications.ersnet.org
Pulmonary hypertension (PH) associated with chronic lung disease (CLD) is both common
and underrecognised. The presence of PH in the setting of lung disease has been …
and underrecognised. The presence of PH in the setting of lung disease has been …
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management
Patients with chronic lung diseases, particularly interstitial lung disease and chronic
obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in …
obstructive pulmonary disease, frequently develop pulmonary hypertension, which results in …
Transitional cell states sculpt tissue topology during lung regeneration
Organ regeneration requires dynamic cell interactions to reestablish cell numbers and tissue
architecture. While we know the identity of progenitor cells that replace lost tissue, the …
architecture. While we know the identity of progenitor cells that replace lost tissue, the …
Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease
D Douglas, L Keating, R Strykowski… - … of Physiology-Lung …, 2023 - journals.physiology.org
Tobacco smoking is an established cause of pulmonary disease whose contribution to
interstitial lung disease (ILD) is incompletely characterized. We hypothesized that compared …
interstitial lung disease (ILD) is incompletely characterized. We hypothesized that compared …
Meaningful Endpoints for Idiopathic Pulmonary Fibrosis (IPF) Clinical Trials: Emphasis on 'Feels, Functions, Survives'. Report of a Collaborative Discussion in a …
G Raghu, M Ghazipura, TR Fleming… - American journal of …, 2024 - atsjournals.org
Background: Idiopathic pulmonary fibrosis (IPF) carries significant mortality and
unpredictable progression, with limited therapeutic options. Designing trials with patient …
unpredictable progression, with limited therapeutic options. Designing trials with patient …
New trends in pulmonary hypertension
S Cullivan, S Gaine, O Sitbon - European Respiratory Review, 2023 - Eur Respiratory Soc
Pulmonary hypertension (PH) is a prevalent disease of the pulmonary vasculature that is
characterised by considerable morbidity and mortality. Substantial efforts have been made …
characterised by considerable morbidity and mortality. Substantial efforts have been made …
Emerging multimodality imaging techniques for the pulmonary circulation
Pulmonary hypertension (PH) remains a challenging condition to diagnose, classify and
treat. Current approaches to the assessment of PH include echocardiography …
treat. Current approaches to the assessment of PH include echocardiography …
Transplantation, bridging, and support technologies in pulmonary hypertension
L Savale, A Benazzo, P Corris… - European …, 2024 - publications.ersnet.org
Despite the progress made in medical therapies for treating pulmonary hypertension (PH), a
subset of patients remain susceptible to develo** a maladaptive right ventricular …
subset of patients remain susceptible to develo** a maladaptive right ventricular …
Treatment of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis: A position statement from the Thoracic Society of Australia and New Zealand 2023 …
Idiopathic pulmonary fibrosis (IPF) is a progressive disease leading to significant morbidity
and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung …
and mortality. In 2017 the Thoracic Society of Australia and New Zealand (TSANZ) and Lung …